Bruhwyler J., Liégeois J.-F., Chleide E., Rogister F., Damas J., Delarge J., Mercier M. (1992) Comparative study of typical neuroleptics, clozapine and new synthetized clozapine analogues: Correlations between neurochemistry and behaviour. Behav Pharmacol 3:567-579.
Bruhwyler J., Liégeois J.-F., Bergman J., Carey G., Goudie A., Taylor A., Meltzer H.Y., Delarge J., Géczy J. (1997) JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: A review of its behavioural properties. Pharmacol Res 36:255-264.
Casey D.E. (1992) The effect of 8-OH-DPAT on haloperidol-induced dystonia in non-human primates. Proc Am Coll Neuropsychopharmacol 49:1992.
Casey D.E. (1993) Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in non-human primates. Psychopharmacology 112:S55-S59.
Casey D.E. (1995) Motor and mental aspects of extrapyramidal syndromes. Int Clin Psychopharmacol 10:105-114.
Casey D.E. (1996) Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys. Psychopharmacology 124:134-140.
Casey D.E., Gerlach J., Christensson E. (1980) Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. Psychopharmacology 70:83-87.
Goudie A., Taylor A. (1998) Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology 135:392-400.
Korsgaard S., Gerlach J., Christensson E. (1985) Behavioral aspects of serotonin-dopamine interaction in the monkey. Eur J Pharmacol 118:245-252.
Laidlaw S.T., Snowden J.A., Brown M.J. (1993) Aplastic anaemia and remoxipride. Lancet 342:1245.
Lieberman J.A., Johns C.A., Kane J.M., Rai K., Pisciotta A.V., Saltz B.L., Howard A. (1988) Clozapine-induced agranulocytosis: Non-cross-reactivity with other psychotropic drugs. J Clin Psychiatry 49:271-277.
Liégeois J.-F., Bruhwyler J., Damas J., Nguyen T.P., Chleide E., Mercier M., Rogister F., Delarge J. (1993) New pyridobenzodiazepine derivatives as potential antipsychotics: Synthesis and neurochemical study. J Med Chem 36:2107-2114.
Liégeois J.-F., Rogister F., Bruhwyler J., Damas J., Nguyen T.P., Inarejos M.O., Chleide E., Mercier M., Delarge J. (1994) Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: Synthesis and neurochemical study. J Med Chem 37:519-525.
Liégeois J.-F., Mouithys-Mickalad A., Bruhwyler J., Delarge J., Petit C., Kauffmann J.-M., Lamy M. (1997) JL 13, a potential successor to clozapine, is less sensitive to oxidative phenomena. Biochem Biophys Res Commun 238:252-255.
Liégeois J.-F., Bruhwyler J., Petit C., Damas J., Delarge J., Géczy J., Kauffmann J.-M., Lamy M., Meltzer H., Mouithys-Mickalad A. (1999) Oxidation sensitivity may be a useful tool for the detection of the hematotoxic potential of newly developed molecules: Application to antipsychotic drugs. Arch Biochem Biophys 370:126-137.
Meltzer H.Y., Matsubara S., Lee J.-C. (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 251:238-246.
Peacock L., Gerlach J. (1999) New and old antipsychotics versus clozapine in a monkey model: Adverse effects and antiamphetamine effects. Psychopharmacology 144:189-197.
Pisciotta A.V. (1990) Drug induced agranulocytosis peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. Blood Rev 4:226-237.
Povlsen U.J., Noring U., Laursen A.L., Korsgaard S., Gerlach J. (1986) Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in cebus monkeys. Clin Neuropharmacol 9:84-90.
Seeman P., Corbett R., Van Tol H.H.M. (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16:93-110.
Van Tol H.H.M., Bunzow J.R., Guan H.-C., Sunahara R.K., Seeman P., Niznik H.B., Civelli O. (1991) Cloning of a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350:614-619.
